John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
Lennar Class A
LEN
$21.1B
| $495K | ﹤0.01% |
+6,715
| New | +$503K |
|
2527
CALL
Edwards Lifesciences
EW
$52.4B
| $493K | ﹤0.01% |
+5,400
| New | +$448K |
|
2528
CALL
PBF Energy
PBF
$7.88B
| $493K | ﹤0.01% |
69,500
+45,600
| +191% | +$297K |
|
2529
PUT
Warner Bros
WBD
$72.5B
| $493K | ﹤0.01% |
+16,400
| New | +$402K |
|
2530
CALL
Royal Bank of Canada
RY
$288B
| $492K | ﹤0.01% |
6,000
+1,000
| +20% | +$77.4K |
|
2531
Cavco Industries
CVCO
$4.52B
| $491K | ﹤0.01% |
+2,800
| New | +$519K |
|
2532
PUT
Olin
OLN
$1.98B
| $491K | ﹤0.01% |
20,000
+6,200
| +45% | +$126K |
|
2533
PUT
Sinclair Inc
SBGI
$1.06B
| $490K | ﹤0.01% |
15,400
-6,800
| -31% | -$162K |
|
2534
PUT
Nucor
NUE
$56.2B
| $489K | ﹤0.01% |
+9,200
| New | +$475K |
|
2535
PUT
ResMed
RMD
$34.1B
| $489K | ﹤0.01% |
+2,300
| New | +$459K |
|
|
TRIB
2536
Trinity Biotech
TRIB
$7.9M
| $489K | ﹤0.01% |
+855
| New | +$424K |
|
2537
PUT
Affiliated Managers Group
AMG
$9.45B
| $488K | ﹤0.01% |
+4,800
| New | +$415K |
|
|
FLIR
2538
PUT
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $487K | ﹤0.01% |
11,100
+3,400
| +44% | +$131K |
|
2539
PUT
Cinemark Holdings
CNK
$4.34B
| $486K | ﹤0.01% |
+27,900
| New | +$351K |
|
2540
CALL
DTE Energy
DTE
$28.3B
| $486K | ﹤0.01% |
+4,700
| New | +$495K |
|
2541
CALL
Logitech
LOGI
$14.1B
| $486K | ﹤0.01% |
+5,000
| New | +$432K |
|
|
AUD
2542
DELISTED
Audacy, Inc.
AUD
| $486K | ﹤0.01% |
196,776
-223,155
| -53% | -$456K |
|
2543
Graphic Packaging
GPK
$3.38B
| $485K | ﹤0.01% |
28,651
-8,284
| -22% | -$125K |
|
|
NVRO
2544
CALL
DELISTED
NEVRO CORP.
NVRO
| $485K | ﹤0.01% |
+2,800
| New | +$453K |
|
2545
CALL
Northern Trust
NTRS
$34.2B
| $484K | ﹤0.01% |
+5,200
| New | +$459K |
|
|
CNBKA
2546
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $483K | ﹤0.01% |
+6,241
| New | +$467K |
|
2547
CALL
Henry Schein
HSIC
$9.99B
| $481K | ﹤0.01% |
7,200
-2,800
| -28% | -$181K |
|
2548
PUT
Jacobs Solutions
J
$17.7B
| $479K | ﹤0.01% |
+5,319
| New | +$451K |
|
2549
CALL
NetEase
NTES
$82.5B
| $479K | ﹤0.01% |
+5,000
| New | +$449K |
|
2550
PUT
Raymond James Financial
RJF
$33.6B
| $478K | ﹤0.01% |
+7,500
| New | +$429K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.